Vaccine Development Stands to Benefit From Results of New Human Immune System Sequencing Project | GenomeWeb

NEW YORK (GenomeWeb) – As part of the first phase of the Human Vaccines Project, researchers at Vanderbilt University have started enrolling subjects for the Human Immunome Program — a study aimed at untangling genetic features of the immune system that influence response to everything from invading pathogens to vaccines.

"Ultimately, the plan is to … get an estimate of the world's immunome, the world's collection of antibodies, if not get them all into the database," James Crowe Jr., Vanderbilt Vaccine Center director and leader of the Human Immunome Program, told GenomeWeb.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

Sponsored by
New England BioLabs

This webinar will provide an update on Phase 2 of the ongoing ABRF Next Generation Sequencing Study, an effort to evaluate the performance of NGS platforms and to identify optimal methods and best practices. Phase 1 of the study focused on RNA sequencing, while Phase 2 is focusing on genomic DNA samples.

Sponsored by
Agilent Technologies

This webinar will provide specific use cases from a molecular pathology lab demonstrating how an automated bioinformatics pipeline can improve somatic variant assessment and reporting.